Table 2.
Vaccines for families adopting internationally
| Vaccines for those who travel | Standard dose/route | Comment |
|---|---|---|
| Update all childhood vaccines for any children in household | ||
| Routine vaccines for adults (administer as needed according to standard schedules and recommendations) | ||
| Hepatitis B | 1.0 mL IM, 3 doses at 0, 1, 6 months | |
| Influenza | 0.5 mL IM, according to season | |
| Measles, mumps, rubella | 0.5 mL SC, documented 2 doses separated by ≥1 month | |
| Pneumococcal polysaccharide | 0.5 mL SC or IM | |
| Polio | 0.5 mL SC | For travel to areas with transmission of polioviruses |
| Td or TdaP | 0.5 mL IM | |
| Varicella | 0.5 mL SC, 2 doses separated by 4–8 weeks | |
| Special vaccines for travel to high- or intermediate-risk areas | ||
| Hepatitis A | 1.0 mL adult/0.5 mL pediatric IM, 2 doses at 0, 6 months | |
| Typhoid | 0.5 mL IM or 4 capsules PO | |
| Travel to high-risk areas or required by destination | ||
| Japanese encephalitis | 0.5 mL ages 1–2, 1.0 mL ages ≥3 SC, 3 doses on days 0, 7, 30 | For travel to parts of Asia |
| Meningococcus | 0.5 mL SC | For travel to endemic and outbreak areas |
| Rabies | 1.0 mL IM, 3 doses on days 0, 7, 21 or 28 | For longer term travel, remote destinations |
| Yellow fever | 0.5 mL SC | For travel to parts of South America and Africa |
Abbreviations: IM, intramuscular; PO, by mouth; SC, subcutaneous; Td, tetanus diphtheria; TdaP, tetanus-diphtheria-acellular pertussis.